Curaleaf (OTCMKTS:CURLF) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Curaleaf (OTCMKTS:CURLF) issued its quarterly earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.02, Zacks reports. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%.

Curaleaf Trading Up 10.5%

Shares of OTCMKTS CURLF traded up $0.96 during trading on Tuesday, reaching $10.12. 441,775 shares of the company traded hands, compared to its average volume of 145,527. The firm’s fifty day simple moving average is $9.55 and its 200 day simple moving average is $8.30. Curaleaf has a 12-month low of $5.40 and a 12-month high of $15.15. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.73 and a current ratio of 1.52.

Analyst Ratings Changes

CURLF has been the subject of several research reports. Citigroup restated a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research lowered shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 13th. Finally, UBS Group set a $6.00 target price on shares of Curaleaf in a report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $6.00.

About Curaleaf

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted.